Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients
Publication

Publications

Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients

Title
Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients
Type
Article in International Scientific Journal
Year
2020-11-12
Authors
Paulo Linhares
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 47
Pages: 877-886
ISSN: 0301-4851
Publisher: Springer Nature
Other information
Authenticus ID: P-00R-C4Y
Abstract (EN): Diffuse gliomas are the most common malignant primary brain tumors and remain incurable. A better knowledge of the tumor etiology is required. Specific single nucleotides polymorphisms (SNPs) rs4977756 (CDKN2A/B), rs6010620 (RTEL1), rs498872 (PHLDB1), rs2736100 (TERT), and rs4295627 (CCDC26) have been associated with glioma susceptibility and are potential risk biomarkers. This study aimed to analyze five SNPs associated with glioma susceptibility, in the Portuguese population. SNPs were genotyped using the Sequenom MassARRAY platform in 127 gliomas and 180 controls. Unconditional logistic regression models were used to calculate odds ratio (OR) and 95% confidence intervals. The false-positive report probability was also assessed. The associations between polymorphisms and survival were evaluated using the log-rank test. It was found that the AG and GG genotypes of the rs4977756 (CDKN2A/B) were associated with an increased risk of gliomas (OR 1.85 and OR 2.38) and glioblastomas (OR 2.77 and OR 3.94). The GA genotype of the rs6010620 (RTEL1) was associated with a decreased risk of glioblastomas (OR 0.45). We also observed that the GA genotype of the rs498872 (PHLDB1) was associated with an increased risk of gliomas (OR 2.92) and glioblastomas (OR 2.39). No significant risk associations were found for the rs2736100 (TERT) and rs4295627 (CCDC26). In addition, the genotype AA of the rs498872 (PHLDB1) was associated with poor overall survival of gliomas patients (AA vs. GA, p = 0.037). The rs6010620 (RTEL1), rs4977756 (CDKN2A/B), and rs498872 (PHLDB1) are associated with glioma risk in the Portuguese population and these data may contribute to understanding gliomas etiology.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 10
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

The importance of the neutrophil-to-lymphocyte ratio in the prognosis of glioma and its subtypes (2020)
Another Publication in an International Scientific Journal
Paulo Linhares
Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance? (2020)
Another Publication in an International Scientific Journal
Paulo Linhares
Early deep brain stimulation in patients with myoclonus-dystonia syndrome (2016)
Another Publication in an International Scientific Journal
Paulo Linhares
Survival Determinants in Glioblastoma: An Insight into Biopsy-Only Patient Outcomes (2024)
Other Publications
Gonçalves, JM; Ferreira, F; Carvalho, B; Polónia, P; Linhares, P
Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients (2024)
Other Publications
Gonçalves, JM; Carvalho, B; Tuna, R; Polónia, P; Linhares, P

See all (45)

Of the same journal

The best CRISPR/Cas9 versus RNA interference approaches for Arabinogalactan proteins' study (2020)
Another Publication in an International Scientific Journal
Moreira, D; Coimbra, S; Lopes, AL
X-Chromosome STR markers data in a Cabo Verde immigrant population of Lisboa (2014)
Article in International Scientific Journal
costa, ha; morais, p; da silva, cv; matos, s; santos, rm; espinheira, r; santos, jc; amorim, a
Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy (2014)
Article in International Scientific Journal
Lima, A; Seabra, V; Martins, S; Coelho, A; Araujo, A; Rui Medeiros
Resistance to endocrine therapy in HR plus and/or HER2+breast cancer: the most promising predictive biomarkers (2021)
Article in International Scientific Journal
Miranda, F; Prazeres, H; Mendes, F; Martins, D; Fernando Schmitt
Interleukin-6 gene -174G > C and -636G > C promoter polymorphisms and prostate cancer risk (2013)
Article in International Scientific Journal
Magalhães JF; Cortinhas AJ; Albuquerque CM; Baptista CS; Ribeiro R; Viegas C; Matos AJ; Machado J; Pires MA; Guedes-Pinto H; Martins-Bessa A; Leitão JC; Bastos E

See all (8)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 02:36:02 | Privacy Policy | Personal Data Protection Policy | Whistleblowing